Go to the list of all blogs
Anna G's Avatar
published in Blogs
Oct 06, 2023
TickeronGET DAILY SIGNALS
Exploring Uptrends: $CI, $HUM, $MOH, $ELV, $OSCR Lead Managed Health Care’s +strong performance!

Exploring Uptrends: $CI, $HUM, $MOH, $ELV, $OSCR Lead Managed Health Care’s +strong performance!

As the Managed Health Care sector experiences a strong performance, this analysis will spotlight on how specific tickers contributed to this uptrend over the last month. We’ll concentrate on $CI, $HUM, $MOH, $ELV, and $OSCR, diving into their performance and market behavior.

💼 Managed Health Care Sector: Elevate Your Trading Game with AI Robots! 💼

If you're keen on exploring the Managed Health Care group, we have the perfect tools to assist you in your trading journey. 🏥📈

🔄 "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" is designed to help you navigate markets in decline. Whether you're a seasoned trader or just starting, this AI robot can provide valuable insights and strategies to thrive in challenging conditions.

⬆️ On the flip side, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" is your go-to companion when markets are on the rise. It offers a tailored approach to capitalize on upward trends and maximize your trading potential.

With these AI-powered tools at your disposal, you can confidently trade within the Managed Health Care sector, adapting to different market conditions and making informed decisions. Elevate your trading game and embark on a journey of trading excellence! 📊🚀

 

Tickers in this Group:
$CI - $HUM - $UNH - $MOH - $CNC - $CVS  - $ELV - $OSCR - $ALHC


Description

Managed Health Care firms offer crucial health, medical, and disability plans aiming to streamline the cost of health care services. Major firms in this sector, including Aetna, Humana Inc., Cigna, UnitedHealthcare, provide insurance through various channels, ultimately aiming to make health care more accessible and affordable to the public.

Market Cap Analysis

With a group average market capitalization of $96.3B, the sector presents a diverse range of companies from $UNH at the pinnacle with $473B to $OSCR at $1.2B. This vast difference outlines the sector's diversity, offering traders various options to invest based on their market cap preference.

High and Low Price Notable News

The sector observed an average weekly growth of 0.45%, with a monthly enhancement of 5.77%. $ALHC leads the growth at 8%, while $ELV experienced a 1.53% decline. These fluctuations provide traders with insights into the tickers’ volatility and potential investment return.

Volume Insights

The sector’s stocks recorded an average weekly volume growth of -1.11%, with a significant decrease in the monthly and quarterly volume growth, which traders should consider when planning their investment strategies.

Fundamental Analysis Ratings

  • Valuation Rating: 40
  • P/E Growth Rating: 73
  • Price Growth Rating: 43
  • SMR Rating: 78
  • Profit Risk Rating: 50
  • Seasonality Score: 52

Ticker Spotlight: $CI, $HUM, $MOH, $ELV, $OSCR

$CI - Cigna Group (The)

$CI has shown a promising upward trend with its 10-day moving average crossing above its 50-day counterpart, signaling a potential buying opportunity with an 86% chance of continued growth.

$HUM - Humana

With its price surging above the 50-day moving average, $HUM indicates a strong upward trend, providing traders an 80% likelihood of further price increase in the upcoming month.

$MOH - Molina Healthcare

$MOH broke its lower Bollinger Band, suggesting a potential rise back towards the middle band. With an 81% chance of upward movement, this ticker presents a promising buy for traders.

$ELV - Elevance Health

$ELV is expected to rebound from its lower Bollinger Band, offering traders a probable 78% chance of engaging in a continued uptrend in the next month.

$OSCR - Oscar Health

Breaking its lower Bollinger Band, $OSCR provides traders with a compelling buy option, boasting an 83% probability of sustaining its upward trend.

With the Managed Health Care sector experiencing a +strong performance, tickers like $CI, $HUM, $MOH, $ELV, and $OSCR are at the forefront of this positive movement. As traders, understanding the nuances of each ticker’s performance, market cap, and volume growth is crucial for making informed investment decisions in this thriving sector.

Related Ticker: CI, HUM, UNH, MOH, CNC, CVS, ELV, OSCR, ALHC

Momentum Indicator for CI turns negative, indicating new downward trend

CI saw its Momentum Indicator move below the 0 level on November 17, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 55 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 59%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CI turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 29 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.

CI moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for CI moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in 226 of 357 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

CI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 175 of 274 cases where CI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.820) is normal, around the industry mean (3.520). P/E Ratio (12.077) is within average values for comparable stocks, (126.353). Projected Growth (PEG Ratio) (0.739) is also within normal values, averaging (0.786). CI has a moderately high Dividend Yield (0.021) as compared to the industry average of (0.009). P/S Ratio (0.264) is also within normal values, averaging (0.569).

The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. CI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 67.69B. The market cap for tickers in the group ranges from 335.99K to 353.79B. UNH holds the highest valuation in this group at 353.79B. The lowest valued company is IHGP at 335.99K.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was -12%. For the same Industry, the average monthly price growth was -11%, and the average quarterly price growth was 1%. PGNY experienced the highest price growth at -1%, while CLOV experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was 80%. For the same stocks of the Industry, the average monthly volume growth was 91% and the average quarterly volume growth was 67%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 44
Price Growth Rating: 54
SMR Rating: 72
Profit Risk Rating: 91
Seasonality Score: -6 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of health insurance services

Industry ManagedHealthCare

Industry
Managed Health Care
Address
900 Cottage Grove Road
Phone
+1 860 226-6000
Employees
67700
Web
https://www.thecignagroup.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.